Primary Immune Deficiency Clinical Trial
Official title:
An Open-Label Study of Ig NextGen 16% Administered by Subcutaneous Infusion in Patients With Primary Immunodeficiency (PID).
The study aims to assess the safety and tolerability of subcutaneous Ig NextGen 16% in patients with Primary Immune Deficiency who require Immunoglobulin (Ig) G replacement therapy. Ig NextGen 16% is a liquid immunoglobulin (antibody) preparation.
This is a Phase 3, open label, multi-centre, study for patients requiring Ig replacement therapy. This study is a follow-on study to patients who have completed the CSLCT-SCIG-05-23 clinical trial and wish to continue subcutaneous treatment with Ig NextGen 16% . Additionally, patients currently receiving IVIg with unacceptable adverse reactions or unable to tolerate IVIg as well as patients receiving alternate IG products via the SC route may be enrolled in this study. Patients must not be eligible for any of the Sponsor's ongoing PID studies that are still open to enrolment. ;
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05321407 -
COVID-19 Vaccine Responses in PIDD Subjects
|
||
| Completed |
NCT01199705 -
Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)
|
Phase 3 | |
| Recruiting |
NCT05070455 -
An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)
|
Phase 4 | |
| Recruiting |
NCT03836690 -
Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation
|
Phase 1 | |
| Completed |
NCT01461018 -
Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)
|
Phase 3 | |
| Completed |
NCT04581460 -
Primitive Immunodeficiency and Pregnancy
|
||
| Recruiting |
NCT05476653 -
A Prospective Monocentric Study to Assess the Concordance of Lung MRI Compared to Chest CT Scan to Assess the Extent and Severity of Bronchial and Parenchymal Pulmonary Lesions in Adult Patients With Primary Immune Deficiency (PID) .
|
N/A | |
| Completed |
NCT00419341 -
Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy
|
Phase 3 | |
| Active, not recruiting |
NCT02868333 -
Determinants of Health Status and Quality of Life in Patients With Primary Immunodeficiencies Inhereted Diagnosed During Childhood
|
N/A | |
| Completed |
NCT01166074 -
Retrospective Chart Review of Subcutaneous IgG Use in Infants
|
N/A | |
| Recruiting |
NCT05932316 -
Evaluating Bronchodilator Response in Patients With Bronchiectasis
|
N/A | |
| Recruiting |
NCT04784364 -
Biologics And Clinical Immunology Cohort at Sinai
|
||
| Completed |
NCT06014463 -
Evaluation of Adult Patients With Immunodeficiency Within the Scope of the ICF
|
||
| Recruiting |
NCT04459689 -
COVID-19 in PID Survey
|
||
| Completed |
NCT02711228 -
Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules
|
Phase 4 | |
| Recruiting |
NCT04919018 -
Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies
|
||
| Completed |
NCT00719680 -
Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)
|
Phase 3 | |
| Terminated |
NCT00023504 -
Antibody Production in Immune Disorders
|
Phase 4 | |
| Recruiting |
NCT00246857 -
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
|
||
| Recruiting |
NCT04565015 -
Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
|
Phase 3 |